Provided by Tiger Trade Technology Pte. Ltd.

PMV Pharmaceuticals

1.67
+0.240016.78%
Post-market: 1.62-0.0539-3.23%19:30 EDT
Volume:3.13M
Turnover:5.12M
Market Cap:126.11M
PE:-1.18
High:1.73
Open:1.44
Low:1.44
Close:1.43
52wk High:1.88
52wk Low:1.02
Shares:75.51M
Float Shares:61.14M
Volume Ratio:7.03
T/O Rate:5.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4131
EPS(LYR):-1.4800
ROE:-70.93%
ROA:-42.39%
PB:1.76
PE(LYR):-1.13

Loading ...

PMV Pharmaceuticals, - Rezatapopt Shows Favorable Safety Profile with 5% Discontinuation Rate Due to Adverse Events

THOMSON REUTERS
·
Sep 01

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data from Pynnacle Phase 2 Pivotal Trial

THOMSON REUTERS
·
Sep 01

PMV Pharmaceuticals Q2 EPS USD -0.34

Reuters
·
Aug 14

PMV Pharma Q2 EPS $(0.34) Beats $(0.39) Estimate

Benzinga Earnings
·
Aug 14

PMV Pharma Q2 FY26 Net Loss Narrows 14.73% to $18.09 Million

Reuters
·
Aug 14

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights

THOMSON REUTERS
·
Aug 14

PMV Pharmaceuticals Q2 Net Income USD -18.086 Million

THOMSON REUTERS
·
Aug 14

PMV Pharmaceuticals Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 03

PMV Pharmaceuticals Coverage Assumed by Ladenburg Thalmann at Buy

Dow Jones
·
Jul 08

PMV Pharmaceuticals shareholders elect two directors at annual meeting

Reuters
·
Jun 05

PMV Pharmaceuticals (NASDAQ:PMVP) Will Have To Spend Its Cash Wisely

Simply Wall St.
·
May 19

PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer

TIPRANKS
·
May 13

PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)

TIPRANKS
·
May 13

PMV Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

PMV Pharma Q1 EPS $(0.34) Beats $(0.39) Estimate

Benzinga Earnings
·
May 12

PMV Pharma Q1 FY26 net loss widens to $18 million

Reuters
·
May 12

BRIEF-PMV Pharmaceuticals Q1 EPS USD -0.34

Reuters
·
May 12

PMV Pharmaceuticals Q1 Operating Expenses USD 19.019 Million

THOMSON REUTERS
·
May 12

PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights

GlobeNewswire
·
May 12

PMV Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
May 05